BacVax, Inc.

BacVax, Inc., a Delaware corporation with headquarters in Phoenix, Arizona, is developing vaccines against bacteria. BacVax holds an Exclusive Patent License Agreement to use the BVP platform in conjunction with additional patent applications targeting bacteria. BacVax has already garnered attention of strategic partners to explore human and animal market opportunities. Our mission is to reduce the burden of bacterial infections on humanity and animals in “the post-antibiotic” era.